US Drug Master Files (USDMFs) have been filed for the following APIs: Perfluorohexyloctane, Adagrasib, and Finasteride Form-I

We’re pleased to share that US Drug Master Files (USDMFs) have been filed for the following APIs: Perfluorohexyloctane, Adagrasib, and Finasteride Form-I. USDMF filing is a key milestone in supporting partners pursuing development and registration programs for the US market. It reflects our continued focus on quality systems, regulatory preparedness, and transparent portfolio progression. For us, portfolio development goes hand in hand with regulatory strategy, ensuring that partners have the right foundation to move forward with confidence.

If you’re evaluating options for US-focused projects or would like to discuss portfolio alignment, feel free to connect at [email protected]